Jamud, Carima A.
HRN: 28-45-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2026
MUPIROCIN 2%, 15G (TUBE)
01/27/2026
02/03/2026
TOPICAL
15g
BID
S/P Pelvic Lap
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines